Literature DB >> 22683204

Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.

Raphael Ceccaldi1, Kalindi Parmar, Enguerran Mouly, Marc Delord, Jung Min Kim, Marie Regairaz, Marika Pla, Nadia Vasquez, Qing-Shuo Zhang, Corinne Pondarre, Régis Peffault de Latour, Eliane Gluckman, Marina Cavazzana-Calvo, Thierry Leblanc, Jérôme Larghero, Markus Grompe, Gérard Socié, Alan D D'Andrea, Jean Soulier.   

Abstract

Fanconi anemia (FA) is an inherited DNA repair deficiency syndrome. FA patients undergo progressive bone marrow failure (BMF) during childhood, which frequently requires allogeneic hematopoietic stem cell transplantation. The pathogenesis of this BMF has been elusive to date. Here we found that FA patients exhibit a profound defect in hematopoietic stem and progenitor cells (HSPCs) that is present before the onset of clinical BMF. In response to replicative stress and unresolved DNA damage, p53 is hyperactivated in FA cells and triggers a late p21(Cdkn1a)-dependent G0/G1 cell-cycle arrest. Knockdown of p53 rescued the HSPC defects observed in several in vitro and in vivo models, including human FA or FA-like cells. Taken together, our results identify an exacerbated p53/p21 "physiological" response to cellular stress and DNA damage accumulation as a central mechanism for progressive HSPC elimination in FA patients, and have implications for clinical care.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22683204      PMCID: PMC3392433          DOI: 10.1016/j.stem.2012.05.013

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  69 in total

1.  p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

Authors:  L Chin; S E Artandi; Q Shen; A Tam; S L Lee; G J Gottlieb; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

2.  Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53.

Authors:  Annette M G Dirac; René Bernards
Journal:  J Biol Chem       Date:  2003-01-27       Impact factor: 5.157

3.  A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal.

Authors:  Michael Milyavsky; Olga I Gan; Magan Trottier; Martin Komosa; Ofer Tabach; Faiyaz Notta; Eric Lechman; Karin G Hermans; Kolja Eppert; Zhanna Konovalova; Olga Ornatsky; Eytan Domany; M Stephen Meyn; John E Dick
Journal:  Cell Stem Cell       Date:  2010-07-08       Impact factor: 24.633

Review 4.  Stems cells and the pathways to aging and cancer.

Authors:  Derrick J Rossi; Catriona H M Jamieson; Irving L Weissman
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

5.  Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice.

Authors:  Mireille Koomen; Ngan C Cheng; Henri J van de Vrugt; Barbara C Godthelp; Martin A van der Valk; Anneke B Oostra; Malgorzata Z Zdzienicka; Hans Joenje; Fré Arwert
Journal:  Hum Mol Genet       Date:  2002-02-01       Impact factor: 6.150

6.  Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis.

Authors:  Mary Mohrin; Emer Bourke; David Alexander; Matthew R Warr; Keegan Barry-Holson; Michelle M Le Beau; Ciaran G Morrison; Emmanuelle Passegué
Journal:  Cell Stem Cell       Date:  2010-07-08       Impact factor: 24.633

7.  Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence.

Authors:  Xiaoling Zhang; Daniel P Sejas; Yuhui Qiu; David A Williams; Qishen Pang
Journal:  J Cell Sci       Date:  2007-04-03       Impact factor: 5.285

Review 8.  Pathophysiologic mechanisms in acquired aplastic anemia.

Authors:  Neal S Young
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

Review 9.  Pathophysiology and management of inherited bone marrow failure syndromes.

Authors:  Akiko Shimamura; Blanche P Alter
Journal:  Blood Rev       Date:  2010-04-24       Impact factor: 8.250

10.  Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis.

Authors:  Brian Freie; Xiaxin Li; Samantha L M Ciccone; Kathy Nawa; Scott Cooper; Catherine Vogelweid; Laurel Schantz; Laura S Haneline; Attilio Orazi; Hal E Broxmeyer; Suk-Hee Lee; D Wade Clapp
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

View more
  143 in total

1.  Damage control and its costs: BM failure in Fanconi anemia stems from overactive p53/p21.

Authors:  Bogdan Dumitriu; Neal S Young
Journal:  Cell Stem Cell       Date:  2012-07-06       Impact factor: 24.633

Review 2.  DNA replication stress: from molecular mechanisms to human disease.

Authors:  Sergio Muñoz; Juan Méndez
Journal:  Chromosoma       Date:  2016-01-21       Impact factor: 4.316

Review 3.  Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.

Authors:  Ronald S Cheung; Toshiyasu Taniguchi
Journal:  Int J Hematol       Date:  2017-06-19       Impact factor: 2.490

4.  Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.

Authors:  Hebist Berhane; Michael W Epperly; Julie Goff; Ronny Kalash; Shaonan Cao; Darcy Franicola; Xichen Zhang; Donna Shields; Frank Houghton; Hong Wang; Peter Wipf; Kalindi Parmar; Joel S Greenberger
Journal:  Radiat Res       Date:  2014-01-07       Impact factor: 2.841

Review 5.  Fanconi anaemia and the repair of Watson and Crick DNA crosslinks.

Authors:  Molly C Kottemann; Agata Smogorzewska
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

6.  Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.

Authors:  Qing-Shuo Zhang; Weiliang Tang; Matthew Deater; Ngoc Phan; Andrea N Marcogliese; Hui Li; Muhsen Al-Dhalimy; Angela Major; Susan Olson; Raymond J Monnat; Markus Grompe
Journal:  Blood       Date:  2016-10-18       Impact factor: 22.113

Review 7.  What is wrong with Fanconi anemia cells?

Authors:  Sharon B Cantor; Robert M Brosh
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors.

Authors:  Naoya M Suzuki; Akira Niwa; Miharu Yabe; Asuka Hira; Chihiro Okada; Naoki Amano; Akira Watanabe; Ken-Ichiro Watanabe; Toshio Heike; Minoru Takata; Tatsutoshi Nakahata; Megumu K Saito
Journal:  Stem Cells Transl Med       Date:  2015-03-11       Impact factor: 6.940

9.  Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039.

Authors:  Hebist Berhane; Ashwin Shinde; Ronny Kalash; Karen Xu; Michael W Epperly; Julie Goff; Darcy Franicola; Xichen Zhang; Tracy Dixon; Donna Shields; Hong Wang; Peter Wipf; Song Li; Xiang Gao; Joel S Greenberger
Journal:  Radiat Res       Date:  2014-06-16       Impact factor: 2.841

10.  mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells.

Authors:  J Li; W Du; S Zhang; F Guo; M O'Connor; G Thomas; S Kozma; B Zingarelli; Q Pang; Y Zheng
Journal:  Leukemia       Date:  2013-03-29       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.